Company · CIK 0001850119 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Century Therapeutics, Inc. · IPSC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 SForm 4 → | Sep 15, 6:25 pm EDT | Gregory RussottiSee Remarks | 2,587 | $1.93 | $4,993 | 509,198 | −0.51% | |
| Sep 14, 2026 SForm 4 → | Sep 15, 6:25 pm EDT | Douglas CarrSVP Finance & Operations | 1,658 | $1.93 | $3,200 | 502,907 | −0.33% | |
| Sep 11, 2026 FForm 4 → | Sep 15, 6:23 pm EDT | Brent PfeiffenbergerPresident and CEO, Director | 13,850 | $1.94 | $26,869 | 3,633,839 | — | |
| Sep 8, 2026 SForm 4 → | Sep 9, 4:35 pm EDT | Gregory RussottiSee Remarks | 534 | $2.05 | $1,095 | 511,785 | −0.10% | |
| Sep 8, 2026 SForm 4 → | Sep 9, 4:34 pm EDT | Douglas CarrSVP Finance & Operations | 254 | $2.05 | $521 | 504,565 | −0.05% | |
| Sep 4, 2026 FForm 4 → | Sep 9, 4:36 pm EDT | Brent PfeiffenbergerPresident and CEO, Director | 463 | $2.11 | $977 | 3,633,839 | — | |
| Aug 14, 2026 FForm 4 → | Aug 18, 4:17 pm EDT | Brent PfeiffenbergerPresident and CEO, Director | 31,172 | $1.92 | $59,850 | 3,634,302 | — | |
| Aug 3, 2026 SForm 4 → | Aug 5, 4:08 pm EDT | Douglas CarrSVP Finance & Operations | 275 | $1.98 | $544 | 504,819 | −0.05% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 AForm 4 → | Sep 10, 5:48 pm EDT | Joseph TruittDirector | 148,000 | — | — | 148,000 | — |